Experimental infection and protection against ... - TI Pharma

54 Chapter 2
13. Ballou WR, Hoffman SL, Sherwood JA, Hollingdale MR, Neva FA et al. Safety and
efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet
1987; 1:1277-1281.
14. Amador R, Moreno A, Valero V, Murillo L, Mora AL et al. The first field trials of the
chemically synthesized malaria vaccine SPf66: safety, immunogenicity and
protectivity. Vaccine 1992; 10:179-184.
15. Lawrence G, Cheng QQ, Reed C, Taylor D, Stowers A et al. Effect of vaccination
with 3 recombinant asexual-stage malaria antigens on initial growth rates of
Plasmodium falciparum in non-immune volunteers. Vaccine 2000; 18:1925-1931.
16. Lawrence GW, Saul A, Giddy AJ, Kemp R, Pye D. Phase I trial in humans of an oilbased
adjuvant SEPPIC Montanide ISA 720. Vaccine 1997; 15:176-178.
17. Saul A, Lawrence G, Smillie A, Rzepczyk CM, Reed C et al. Human phase I vaccine
trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720
adjuvant. Vaccine 1999; 17:3145-3159.
18. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF et al. A recombinant bloodstage
malaria vaccine reduces Plasmodium falciparum density and exerts selective
pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J
Infect Dis 2002; 185:820-827.
19. Aucouturier J, Dupuis L, Deville S, Ascarateil S, Ganne V. Montanide ISA 720 and
51: a new generation of water in oil emulsions as adjuvants for human vaccines.
Expert Rev Vaccines 2002; 1:111-118.
20. Heppner DG, Jr., Kester KE, Ockenhouse CF, Tornieporth N, Ofori O et al. Towards
an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria:
progress at the Walter Reed Army Institute of Research. Vaccine 2005; 23:2243-
2250.
21. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E et al. Duration of protection
with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum
disease in Mozambican children: single-blind extended follow-up of a randomised
controlled trial. Lancet 2005; 366:2012-2018.
22. Aponte JJ, Aide P, Renom M, Mandomando I, Bassat Q et al. Safety of the
RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of
Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet 2007;
370:1543-1551.
23. Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A et al. Efficacy of
RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semiimmune
adult men in The Gambia: a randomised trial. Lancet 2001; 358:1927-
1934.
24. Gordon DM, McGovern TW, Krzych U, Cohen JC, Schneider I et al. Safety,
immunogenicity, and efficacy of a recombinantly produced Plasmodium